Table.4.
Characteristic | Studies, n (n = 37) |
Patients, n (n = 8555) |
Median cumulative incidence of patients retransitioninga |
---|---|---|---|
Manner of providing information | |||
Both written and verbal information from HCP | 13 | 1918 | 19.4 (6.7–19.7) |
Written information | 1 | 758 | 9.9 |
Verbal information from HCP | 6 | 590 | 4.7 (0.5–25.7) |
Not reported | 17 | 5289 | 7.4 (3.6–15.2) |
Training of HCPs | |||
Both educational and communication | 2 | 670 | 2.7 (2.7–2.9) |
Educational | 4 | 315 | 6.8 (1.4–33.4) |
Communication | 1 | 89 | 25.8 (NA) |
Not reported | 30 | 7481 | 7.1 (5.2–10.1) |
Type of consent | |||
Informed consent | 13 | 2189 | 1.6 (1.4–7.6) |
Opt in | 9 | 2030 | 9.0 (3.4–24.3) |
Opt out | 3 | 1838 | 9.7 (5.0–13.1) |
Not reported | 12 | 2498 | 7.4 (5.3–16.0) |
Gainsharing | |||
Yes | 2 | 256 | 1.4 (1.4–1.5) |
No | 0 | 0 | – |
Not reported | 35 | 8299 | 7.2 (5.4–17.2) |
Option offered to retransition | |||
Yes | 5 | 463 | 11.1 (4.1–20.0) |
No | 0 | 0 | – |
Not reported | 32 | 8092 | 7.0 (5.3–7.8) |
Extra control visits | |||
Yes | 14 | 1473 | 5.4 (1.6–17.5) |
No | 16 | 4690 | 7.1 (6.8–27.8) |
Not reported | 7 | 2392 | 18.3 (9.4–26.0) |
Extra laboratory monitoring | |||
Yes | 15 | 2460 | 1.6 (2.0–2.7) |
No | 12 | 3320 | 6.1 (4.8–7.0) |
Not reported | 10 | 2775 | 5.8 (3.8–13.7) |
HCP healthcare professional
aData are presented as weighted % (interquartile range)